Investigation of the Effect of Proximal and Distal Adductor Canal Block in Knee Replacement Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: ADDUKTOR CANAL BLOCK, CONTROL GROUP.
- Who it may be relevant to
- Registry conditions: Knee Osteoarthritis. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Investigation of the Effect of Proximal and Distal Adductor Canal Block on Pain Control and Functional Mobility in Total Knee Prosthesis Surgery Performed Under Spinal Anesthesia
Overview
to investigate the effect of adductor canal block applied with two different approaches in the treatment of pain after TKA surgery on pain control and functional mobility.
Detailed description
This prospective randomized trial is randomly divided into 3 groups using the method. Total knee arthroplasty is performed by the same surgical team.
is applied. The patients were divided into proximal ACB applied, distal ACB applied and control groups.
Interventions
- Other ADDUKTOR CANAL BLOCK
All patients who will undergo adductor canal block are sedated with midazolam 0.03 mg/kg in the preoperative preparation room, after standard monitoring. After 2-3 ml skin infiltration with 2% lidocaine under sterile conditions, a block is applied under USG guidance.To verify block success, sensory function is assessed by pinprick testing along the saphenous nerve distribution by comparing the pinprick sensation to the unaffected limb.All patients are monitored in the operating room and in a sit - Other CONTROL GROUP
No nerve block procedure is applied to patients.All patients are monitored in the operating room and in a sitting position, 10-20 mg (2-4 ml) of heavy marcaine (0.5% bupivacaine hydrochloride and dextrose monohydrate) is applied to the subarachnoid space by entering the L3-4 or L4-5 space with a 25-gauge Whitrace needle.For postoperative multimodal analgesia, which is routinely applied to all patients, intravenous PCA (patient controlled analgesia) tramadol 50 mg at 10 mg / hour basal rate after
Primary outcome measures
- VISUAL ANALOGUE SCALE(VAS) [Time frame: POSTOPERATIVE 6, 12 AND 24 HOURS]
Secondary outcome measures (3)
- first mobilization time [Time frame: within postoperative 24 hours]
- length of hospital stay [Time frame: ONE WEEK]
- opioid use [Time frame: within postoperative 24 hours]
Eligibility criteria
Inclusion criteria
- Medications for unilateral TKA surgery
- Patients aged 18-85
- ASA 1-3
Exclusion criteria
- Patients under 18 years of age and over 85 years of age
- Patients with ASA 4 and above
- Patients with cognitive impairment
- Patients with application site infection
- Patients allergic to local anesthesia
- Patients receiving anticoagulant therapy
- Patients with bleeding diathesis
- Patients with chronic opioid or substance use
- Patients with insulin-dependent diabetes mellitus
- patients with neuropathy
- patients with hepatic or renal failure
- Patients who do not accept the procedure to be applied
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Umraniye Education and Research Hospital — Istanbul
Identifiers
NCT: NCT06188806 · URH-AR-ZT-06